ELIZABETH TIMOTHY: Open Payments
NPI 1760825582 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 41 payments from 17 companies in 2025. Trend: 2023 $970 · 2024 $532 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $207 |
| Corcept Therapeutics | 8 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Boston Scientific Corporation | 1 | $33 |
| PFIZER INC. | 2 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: Korlym, VRAYLAR, QULIPTA, TRINTELLIX, WATCHMAN Access System, Tlando, Auvelity, RECORLEV.
Industry payments across UT — which companies pay providers there.
